IMRIS Reports Strong Financial Growth Following Two-Year Anniversary Under New Ownership Post author:Sam Post published:September 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies September 6, 2017 Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm January 3, 2018 What You Need to Know About Relay Therapeutics January 4, 2018